Table 4. Physician toxicity evaluation according to CTCAE v5.0-JCOG after NMN treatment.

Results are expressed as mean ± standard deviation (n = 10). NMN: Nicotinamide mononucleotide.

CTCAE: Common Terminology Criteria for Adverse Events; JCOG: Japan Clinical Oncology Group

Characteristics	Pretreatment	Post-treatment
Chills	0 (±0)	0 (±0)
Edema face	0 (±0)	0 (±0)
Fatigue	0 (±0)	0 (±0)
Gait disturbance	0 (±0)	0 (±0)
Infusion site extravasation	0 (±0)	0 (±0)
Injection site reaction	0 (±0)	0 (±0)
Malaise	0 (±0)	0 (±0)
Pain	0 (±0)	0 (±0)